Interventions for treating intrahepatic cholestasis in people with sickle cell disease

Abstract

Interventions for treating intrahepatic cholestasis in people with sickle cell disease.

Successful treatment of acute sickle cell intrahepatic cholestasis with therapeutic plasma exchange

“…Left untreated, it can cause progressive liver damage and ultimately overt liver failure [ 1 ]. Even though there is no robust evidence on the benefit of any therapeutic intervention [ 2 ], red cell exchange (RCE) is widely accepted as the mainstay of treatment as it can greatly improve clinical outcomes [ 3 ].…”